Rusk Rehabilitation Brooklyn at Sunset Terrace Family Health Center | NYU Langone Health
NYU Langone’s Rusk Rehabilitation Brooklyn at Sunset Terrace Family Health Center provides rehabilitation therapy to adults recovering from illness or injury.
Rusk Rehabilitation Doctors | NYU Langone Health
Find a doctor at the Rusk Rehabilitation at NYU Langone.
Rusk Rehabilitation Wellness Services | NYU Langone Health
The team at NYU Langone’s Rusk Rehabilitation offers wellness services such as acupuncture and massage to complement your treatment.
Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter with the TRUPULSE Generator for treatment of drug refractory symptomatic Paroxysmal Atrial Fibrillation (PAF)
This is a prospective, single arm, multi-center, clinical evaluation of the PF/RF ablation system (THERMOCOOL SMARTTOUCH™ SF (STSF) Catheter and TRUPULSE™ Generator) to demonstrate safety and effectiveness of the system for the treatment of Paroxysmal Atrial Fibrillation (PAF) comparing to corresponding performance goals.
Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure (ALLAY-HF)
ALLAY-HF is a prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF. Patients will be randomized in a 1:1 ratio to undergo the investigational device procedure or a sham-control procedure. The primary analysis will be performed after all study subjects have the opportunity to complete 12 months of follow-up. Regular follow-up visits are planned to occur through 5 years after the index procedure for all study subjects. Sham-control subjects will be offered an opportunity to cross-over after the 24-month follow-up and undergo the investigational device procedure if they meet study eligibility criteria at that time.
Safety and Immune Response Study of An Intranasal COVID-19 Booster Vaccine
The NYU Langone Vaccine Center Long Island site is enrolling adult volunteers, aged 18-64, for a clinical trial evaluating a new investigational NIH-DMID intranasal COVID-19 booster vaccine. If you are eligible and decide to participate, you may be asked to complete 9-in person clinic visits at the Vaccine Center-Long Island site, as well as 1 phone call, over one year. You will be compensated $90 for screening visit, $135 for vaccination visit, and $110 for most follow-up visits.
Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective Randomized Trial
This safety study is a Phase 3, prospective, open-label, randomized (1:1 ratio), parallel group study of GTX-104 (nimodipine injection for IV infusion) compared with oral nimodipine, in subjects hospitalized for aSAH.Oral nimodipine is approved by the Food and Drug Administration (FDA) for “improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).”The purpose of this study is to evaluate the safety and tolerability of GTX-104 compared to oral nimodipine.
Sala Child & Family Support | NYU Langone Health
Hassenfeld Children’s Hospital at NYU Langone provides programs and services that support children and families.
Sala Family Advisory Council | NYU Langone Health
The Sala Family Advisory Council is a partner in advancing Hassenfeld Children’s Hospital’s model of patient- and family-centered care.
Sala Institute for Child & Family Centered Care | NYU Langone Health
Sala Institute for Child and Family Centered Care leads support, quality, and safety efforts at Hassenfeld Children’s Hospital at NYU Langone.